# FDA Inspection 1244008 - Infar, S.A. - April 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/infar-sa/7425a759-b56f-4c50-8fa3-44ac80a9cc3b
Source feed: FDA_Inspections

> FDA Inspection 1244008 for Infar, S.A. on April 20, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1244008
- Company Name: Infar, S.A.
- Inspection Date: 2023-04-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1118166 - 2019-04-11](https://www.keypedia.com/records/fda_inspections/infar-sa/d7bb2829-acf2-4f85-8c88-cac9b9f6bb30)
- [FDA Inspection 957807 - 2016-01-15](https://www.keypedia.com/records/fda_inspections/infar-sa/d8e57a0d-a0ab-459f-b99b-96062dc861ee)
- [FDA Inspection 847083 - 2012-11-09](https://www.keypedia.com/records/fda_inspections/infar-sa/91091754-5e00-4e95-afd7-9bc9286a814e)

Company: https://www.keypedia.com/companies/infar-sa/7b158806-34b5-4073-abb1-de56bb34a267

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c